Host: Gates B. Colbert, MD Guest: Kelly Helm Over 35 million people in the United States suffer from some form of chronic kidney disease, but many of them lack the support and education to navigate their condition and receive the best possible care. After her daughter was diagnosed with a rare kidney disease, Kelly Helm discovered the many obstacle…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sara Enslin, PA Current colorectal cancer (CRC) screening rates are low, putting patients at risk of developing more advanced disease and even increased mortality. Primary care physicians play a critical role in reversing this troubling trend, which is why Dr. Charles Turck speaks with Ms. Sarah Ensli…

Host: Matt Birnholz, MD For patients at average risk of colorectal cancer (CRC), the United States Preventative Services Task Force recommends screening with either the multi-target stool DNA test or fecal immunochemical test. But in light of new performance data that compared a multi-target stool DNA test and a fecal immunochemical test, a poster …

Host: Matt Birnholz, MD The United States Preventative Services Task Force endorses multiple screening options for patients at average-risk of colorectal cancer (CRC). These options include colonoscopy, multi-target stool DNA, and the fecal immunochemical test. However, performance data for non-endorsed options like multi-target stool RNA and blood…

Host: Jennifer Caudle, DO Guest: A. Mark Fendrick, MD Approximately 40 percent of the eligible U.S. population are not up to date with their colorectal cancer (CRC) screenings, which inspired this study that was presented at Digestive Disease Week (DDW) 2024 to help eliminate the colonoscopy backlog with stool-based CRC screening options. To learn …

Guest: Ina Park, MD The United States has seen its largest increase in syphilis cases in the past five years. And with increases prevalent in every region, along with a shortage of medication, additional surveillance strategies and importation resources are necessary. Dive in for a discussion on the challenges and strategies to combat the spread of…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Melanie Dispenza, MD The future therapeutic landscape for food allergy prevention is looking clearer as a drug typically used to treat hematologic malignancies has shown to prevent systemic anaphylaxis to allergens and increase patients' tolerance to peanuts. Along with this, other therapies are also …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Henry Rosenberg, MD Malignant hyperthermia is an inherited disorder primarily recognized by anesthesia professionals. And since this condition can have significant consequences on a patient’s health, including their likelihood of surviving surgery, it’s important to know how to diagnose and treat mali…

Host: Charles Flexner, MD Daily oral therapy can have low adherence, which is why the field of long-acting formulations is rapidly advancing. Tune in to hear Dr. Charles Flexner discuss how long-acting regimens can address this problem of adherence and help patients living with HIV, tuberculosis, malaria, and other infectious diseases. Dr. Flexner …

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Christin Iroegbu PhD, RN If left untreated, chronic kidney disease (CKD) can progress to end-stage renal disease, requiring dialysis or kidney transplant as the only treatment options. So communicating this to patients, along with chronic conditions that could contribute to this are key. …

Host: Jennifer Caudle, DO Guest: Sayantani Sindher, MD Recently, Omalizumab was studied in patients due to the avoidance of management and guidance when it comes to treating food allergies in children and adults. According to this doctor, approximately 45 percent of patients seen in his clinic have multi-food allergies that are not being met with c…

Guest: Douglas Jones, MD A recent study was done to show the side effects of diphenhydramine for allergic reactions, and one of the main detriments was that it could impair the patient by making them tired or sleepy. Another finding was that it doesn’t work that quickly, so in turn, giving diphenhydramine in a severe allergic reaction could cause m…

Guest: Gates B. Colbert, MD A class of medications called SGLT2 inhibitors have been proven to make a major difference for patients with chronic kidney disease (CKD) with and without diabetes when added to angiotensin converting enzyme (ACE) and angiotensin receptor blockers (ARB) classes of medications. Several medications that have been well stud…

Host: Michael Greenberg, MD Guest: Chris Bundy, MD, MPH, FASAM Clinicians experiencing substance abuse disorder (SUD) may have some reluctance about utilizing a Physician Health Program; however, it’s important to know what your resources are in terms of formal treatment and to seek a psychiatrist with addiction specialization. Dive into part two o…

Host: Ashley Baker, MSN, PMHNP Guest: Chi D. Chu, MD, MAS The National Health and Nutrition Examination Survey found that kidney disease awareness among patients in the U.S. is very low. And alarmingly, the proportion of awareness has not changed much over the 15-year period of this study. To uncover more of the findings and how to improve CKD awar…

Host: Michael Greenberg, MD Guest: Chris Bundy, MD, MPH, FASAM Along with the general population, physicians are vulnerable to substance use disorder (SUD) with rates as high as 10 to 14 percent. And with demanding careers, stress and burnout can often exacerbate SUD. Tune into part one of this discussion with Dr. Michael Greenberg as he takes a de…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Basil M. Kahwash, MD Patients with asthma who have experienced challenges with exercise may find that they are hesitant to exercise again in the future, or they may think it’s not safe to pursue. However, artificial intelligence (AI) may be a useful tool in promoting exercise in asthma patients due to…

Host: Jennifer Caudle, DO Guest: Manpreet Mundi, MD Enteral nutrition intolerance is quite prevalent as it can be seen in up to 40 percent of patients who are tube fed. Due to the significant consequences of intolerance, there’s an urgency to manage patients symptoms, and one option that’s been shown to help is peptide-based tube feeding formulas. …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Justin Reinert, PharmD Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by the rapid onset of widespread inflammation in the lungs, but inhaled epoprostenol can be used as a last-line treatment strategy for these patients. Learn more about this treatment option’s eff…

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Basil M. Kahwash, MD Patients with asthma could benefit greatly from exercising, and over time, it could lead to better asthma control. Dive into this episode to learn more about the findings from a recent study on exercise and asthma with Dr. Mary Katherine Cheeley and Dr. Basil Kahwash,…

Host: Charles Turck, PharmD, BCPS, BCCCP Emerging data over the years has shown the role of GLP-1 receptor agonists, not only in terms of their initial role in managing diabetes and blood sugar but also the secondary benefit of sometimes massive amounts of weight loss. However, there hasn’t been a tremendous number of studies looking at the use of …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ananta Paine, PhD The diagnosis of psoriatic arthritis has not been easy due to the lack of knowledge about an established biomarker. To learn more, join Dr. Charles Turck as he speaks with Dr. Ananta Piane, Principal Investigator and Research Assistant Professor at the University of Rochester Medical…

Host: Andrew Wilner, MD, FACP, FAAN Guest: Neil Skolnik, MD The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recently updated some of the recommendations for treating patients with chronic obstructive pulmonary disease (COPD). Two large conceptual changes occurred in this update: one is an increased emphasis on treating exacerbatio…

Host: Jennifer Shu, MD, FAAP Guest: Steven H. Abman, MD Bronchopulmonary dysplasia is a chronic lung disease that can have significant impacts on a newborn’s overall respiratory health, making it imperative to know how to recognize and treat it. Tune in to hear Dr. Jennifer Shu talk about the symptoms, impacts, and treatment of bronchopulmonary dys…

Host: Dalmacio Dennis Flores, PhD, ACRN, FAAN According to a Gallup poll, Generation Z youth identify as LGBTQ more than previous generations. Given this increasing prevalence, clinicians need to know how to foster synergistic relationships between parents and LGBTQ+ youth. Here to discuss this important topic is Dr. Dalmacio Dennis Flores, an Assi…

Host: Jeffrey Kwong, DNP, MPH Managing co-occurring conditions in patients with HIV can be challenging. But by taking certain steps—like updating management guidelines, screening for complications, and implementing prevention strategies—we can overcome those challenges and improve the way we care for HIV patients with co-occurring conditions. Here …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: William R. Short, MD, MPH, AAHIVS As of January 2023, the breastfeeding guidelines for HIV patients were updated, and they now recommend supporting the parent’s choice through shared decision-making. Joining Dr. Charles Turck to share what these new guidelines look like in practice and key counseling …

Host: Rachel Denyer, MD About one in every three people living with HIV has a positive hepatitis B core antibody. But how frequently does hepatitis B reactivation occur after a patient with HIV switches to an antiretroviral regimen that has no hepatitis B activity? Find out with Dr. Rachel Denyer as she shares key data she presented at IDWeek 2023 …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stuart M. Levitz, MD Treating fungal infections can be difficult due to the limited treatment options available, but could antifungal vaccines help change that? To catch us up on the progress being made in immunotherapeutic and vaccine strategies, Dr. Charles Turck speaks with Dr. Stuart Levitz about …

Host: Jeffrey Freiberg, MD, PhD The field of infectious diseases is always evolving thanks to new research studies, data, and treatment options. To help us catch up on some of these essential updates, Dr. Jeffrey Freiberg is here to give us an overview of the “What's Hot in ID in Clinical Science” session he helped develop for IDWeek 2023.…

Host: Jay Fishman, MD With a global shortage of human organs, xenotransplantation offers a potential new way to save lives. But what are the immunologic barriers? Tune in as Dr. Jay Fishman, Director of Transplant Infectious Diseases and Compromised Host Program at Massachusetts General Hospital, recaps his session from the 2023 IDWeek.…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Allison Andreno Norful, PhD, MPhil, MSN, BSN, ANP-BC Emergency departments are demanding, causing ER nurses to experience high levels of work-related stress, and they're at a higher risk of burnout now more than ever before. But what are the causes and factors specific to emergency nurses that can lea…

Guest: Terry M. Foster, MSN, RN, CEN, CPEN, CCRN, TCRN, FAEN Attendees can expect a wide range of education sessions, keynote presentations, networking events, and hands-on learning experiences from this year’s Emergency Nurses Association (ENA) annual meeting. Hear from ENA President, Terry Foster, Critical-Care Clinical Nurse Specialist in the Em…

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Valeria Cantos Lucio, MD HIV diagnoses in the United States have declined two-thirds since the start of the pandemic in the 1980s. However, the Latino community are still facing high risk of infections. To learn more on providing better access to care for these patients, join Dr. Mary Kat…

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Dylan Baker, MD Georgia has the highest rate of new HIV diagnoses out of any state in the country, and so it’s imperative that we make this medication more accessible now in order to save future generations from living with HIV. To dive further into the benefits and challenges of this pro…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sorana Segal-Maurer, MD Research has shown that those living with HIV are more likely to be malnourished and experience nutrient deficiencies that play an essential role in their immunity. In the early days of HIV, a typical recommendation was to increase a patient’s calorie count. To discuss how the …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Sorana Segal-Maurer, MD For most patients living with HIV, antiretroviral therapy is extremely effective. However, HIV mutates with frequency, allowing it to become resistant to antiviral medication. To discuss how we can effectively treat these patients, Dr. Charles Turck is joined by Dr. Sorana Sega…

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Sarah Bauerle Bass, PhD, MPH, FSBM Although the rate of new HIV diagnoses in the United States is steadily declining, people in prisons are still disproportionately living with the virus, which is why researchers at Temple University are now developing an app aimed at improving HIV preven…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kamel Khalili, PhD Scientists at Temple University’s Lewis Katz School of Medicine have identified a novel gene-editing strategy aimed at eliminating HIV-1 infection with no adverse effects on cell mortality. Find out how this recent discovery could get us one step closer to a cure for HIV with Dr. Ch…

Host: Michael Greenberg, MD Guest: William E. Hauter, MD Illinois lawmakers are taking steps to end intrusive mental health questionnaires for physician licensures. To learn more about Illinois House Bill 3109 and how you can get involved, join Dr. Michael Greenberg as he sits down with Dr. Bill Hauter, Illinois State Representative and Anesthesiol…

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered associations between socioeconomic factors and visit adherence among patients with glaucoma. Can clinicians use this data to improve visit adherence? Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biome…

Host: Frank Cortazar, MD There are several challenges associated with the management of glomerular diseases like IgA nephropathy and C3 glomerulopathy. But in order to overcome those challenges, we must first have a firm understanding of them. That’s why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to bre…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Gates B. Colbert, MD When managing a rare disease like IgA nephropathy (IgAN), it’s essential to keep each individual patient at the center of it all, and this type of approach starts at the diagnostic stage. Joining Dr. Charles Turck to share strategies for providing patient-centered care throughout …

Host: Frank Cortazar, MD Have you ever heard or thought that IgA nephropathy (IgAN) is only a short-term disease? Or that it’s benign? These are just some of the many common misconceptions surrounding IgAN, which is why Dr. Frank Cortazar from the New York Nephrology Vasculitis and Glomerular Center is here to help debunk these and other prevalent …

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Carl P. Walther, MD The alternative complement pathway and the lectin pathway are the two pathways that are important in IgA nephropathy (IgAN). So how does the dysregulation of these two pathways impact disease progression, and how might this knowledge help us optimize our approach to treating patien…

Host: Mario R. Nacinovich, Jr., MSc Guest: Sally L. Baxter, MD, MSc The All of Us Research Program discovered how socioeconomic factors such as lower income and education levels were associated with lower odds of seeing an eye doctor. Mario Nacinovich joins Dr. Sally Baxter, an Assistant Professor of Ophthalmology and Biomedical Informatics at the …

Host: John Russell, MD Guest: Stanton Miller, MD, MPH, FACS Patients who live in an environment impacted by gun violence may face lifelong challenges. But addressing gun violence from a public health standpoint may help clinicians manage the biological, behavioral, and social aspects of this disease. Dr. John Russell is joined by Dr. Stan Miller fr…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Andrew Clark, MD Emerging treatment options have helped patients with HIV live longer, but the aging population faces its own unique challenges. To explore how we can combat these challenges—including the ongoing stigma around HIV—Dr. Charles Turck is joined by Dr. Andrew Clark, who is the Global Medi…

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: W. Frank Peacock, MD For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.…

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP Physicians and advanced practice registered nurses (APRNs) may practice differently but they can still get their patient to the same outcome. So where do the conflicts arise? Join Dr. Peter Buch as he walks us through this with Dr. Wendy Wright, nurse…